140
Participants
Start Date
February 23, 2021
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2026
INCB057643
INCB057643 dose escalation and dose expansion.
Ruxolitinib
Ruxolitinib will be administered twice a day using the dose described for each Cohort in the protocol for Part 2.
Nyu Langone Laura and Isaac Perlmutter Cancer Center, New York
Weill Medical College of Cornell University, New York
Azienda Ospedaliero Universitaria San Luigi Gonzaga Di Orbassano, Orbassano
Nyu Langone Health - Long Island Hospital, Mineola
Fondazione Irccs Ca Granda Ospedale Maggiore, Milan
University of North Carolina At Chapel Hill, Chapel Hill
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Virgen de La Arrixaca, Murcia
Emory University-Winship Cancer Institute, Atlanta
University of Miami Sylvester Comprehensive Cancer Center, Miami
Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria
University of Alabama At Birmingham, Birmingham
Hospital Clinico Universitario de Salamanca, Salamanca
Centro Ricerche Cliniche Di Verona, Verona
Aou Policlinico S. Orsola-Malpighi, Bologna
Ohio State University, Columbus
University of Cincinnati Cancer Institute, Cincinnati
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori, Meldola
Azienda Ospedaliero-Universitaria Careggi (Aouc), Florence
University of Iowa Hospital and Clinics, Iowa City
Washington University School of Medicine, St Louis
Texas Oncology-Baylor Sammons Cancer Center, Dallas
Md Anderson Cancer Center, Houston
Oncology Consultants, Houston
University of Colorado Cancer Center, Aurora
Huntsman Cancer Institute At University of Utah, Salt Lake City
Oregon Health and Science University, Portland
Fred Hutchinson Cancer Center, Seattle
Peking Union Medical College Hospital, Beijing
The First Affiliated Hospital, Zhejiang University School of Medicine (Fahzu), Hangzhou
Henan Cancer Hostipal, Zhengzhou
Nanfang Hospital_Southern Medical University, Guangzhou
Rutgers Cancer Institute of Nj, New Brunswick
Princess Margaret Cancer Center, Toronto
McGill University Jewish General Hospital, Montreal
St Paul'S Hospital, Vancouver
Helsinki University Central Hospital, Helsinki
Fujita Health University Hospital, Aichi
Chiba University Hospital, Chiba
National Cancer Center Hospital East, Chiba
University of Yamanashi Hospital, Chūō
Kyushu University Hospital, Fukuoka
Kumamoto Shinto General Hospital, Kumamoto
Hospital Universitari Germans Trias I Pujol, Badalona
United Lincolnshire Hospitals, Boston
Lincoln County Hospital, Lincoln
The Christie Nhs Foundation Trust Uk, Manchester
University of Oxford, Oxford
Lead Sponsor
Incyte Corporation
INDUSTRY